While hepatic p53 expression is elevated in patients with NASH [46,47] and positively correlates with the degree of steatosis [47], WAT p53 seems to play a specific role as a negative regulator of adipogenesis [45] and reduces lipid droplet accumulation [48]. Here, TP53 is linked to metabolic dysfunction-associated steatohepatitis.